Clinical Trial Update: Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

View source ↗

Summary

A clinical trial update evaluating the efficacy and safety of sacituzumab govitecan in patients with ovarian clear cell carcinoma after progression on immunothe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Clear Cell Carcinoma

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Ovarian Cancer, Antibody-drug Conjugates | Status: NOT_YET_RECRUITING